Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is WEED stock a buy?

| More on:
A cannabis plant grows.

Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Similar to most other cannabis stocks, Canopy Growth (TSX:WEED) trailed the broader markets by a wide margin in 2022. Currently valued at a market cap of $1.6 billion, Canopy Growth stock fell by 72% last year and is now down 96% from all-time highs.

Created with Highcharts 11.4.3Canopy Growth PriceZoom1M3M6MYTD1Y5Y10YALLstaging.www.fool.ca

But Canopy Growth has a well-established presence in Canada and is among the largest marijuana producers in the world. So, let’s see what impacted WEED stock in 2022 and if it can stage a comeback this year.

A look at Canopy Growth‘s profit margin

At its peak, Canopy Growth was valued at more than 25 times forward sales. Right now, WEED stock is priced at less than four times fiscal 2024 sales (ending in March). Canadian cannabis companies have been under the pump since 2019 due to an increase in competition and cannibalization from a thriving black market, thereby accelerating cash-burn rates and weakening their balance sheets.

In the last three years, Canopy Growth’s gross margins have narrowed significantly. Further, its revenue in fiscal Q2 of 2023 grew by just 10% to $118 million.

In recent years, Canopy Growth and its peers focused on expanding sales of high-margin products such as edibles and marijuana concentrates to drive bottom-line growth. But its falling gross profits indicate Canopy’s plan is still a work in progress.

The company is now looking to exit an oversupplied Canadian retail market and create a presence south of the border in the hope that marijuana will be legalized at the federal level in the United States. In fiscal 2022, Canopy’s operating expenses totaled $450 million, and it also reported a net loss of $302 million. So, a divesture of its Canadian business will help reduce losses and free up liquidity to gain a foothold in the world’s biggest cannabis market.

Canopy has partnerships with a few cannabis operators in the U.S., allowing it to have a presence in 21 states in the country.

But it might take at least a few more years (if not more) for recreational marijuana to be legalized federally in the U.S.

Is WEED stock a buy right now?

In the September quarter, Canopy Growth’s recreational marijuana sales fell by 35%, its B2B (business-to-business) model declined by 40%, and retail sales were down 23%. In the last two years, recreational sales have fallen by 37% from $61 million.

The company also reported a negative free cash flow of $135.4 million in the quarter — an increase of 34% year over year. It ended the quarter with more than $1 billion in cash, indicating Canopy Growth will have to shore up profits and race toward profitability within the next 36 months.

It might be tempting to invest in Canopy Growth stock, given its deep pockets and leadership position in Canada. But it would be prudent to wait until cannabis is legalized in the U.S. to even think about this fundamentally weak stock right now.

Analysts remain bullish on WEED stock and expect shares to gain more than 30% in 2023. But for me, it remains a high-risk bet with little upside potential.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »